Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.
2.

Drug initiatives to improve cognitive function.

Marder SR.

J Clin Psychiatry. 2006;67 Suppl 9:31-5; discussion 36-42.

3.

Developing drugs for cognitive impairment in schizophrenia.

Breier A.

Schizophr Bull. 2005 Oct;31(4):816-22. Epub 2005 Sep 8. Review.

PMID:
16150959
4.

Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment.

Sharma T, Antonova L.

Psychiatr Clin North Am. 2003 Mar;26(1):25-40. Review.

PMID:
12683258
5.

A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR.

Schizophr Bull. 2005 Jan;31(1):5-19. Epub 2005 Feb 16.

PMID:
15888422
6.

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR.

Am J Psychiatry. 2008 Feb;165(2):203-13. doi: 10.1176/appi.ajp.2007.07010042. Epub 2008 Jan 2.

PMID:
18172019
7.

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR.

Biol Psychiatry. 2004 Sep 1;56(5):301-7. Review.

PMID:
15336511
8.
9.

Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.

Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP.

J Clin Psychiatry. 2009 Jan;70(1):104-12. Epub 2008 Nov 18. Review.

PMID:
19026265
11.

Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia.

Cho RY, Ford JM, Krystal JH, Laruelle M, Cuthbert B, Carter CS.

Schizophr Bull. 2005 Oct;31(4):865-9. Epub 2005 Sep 15.

PMID:
16166611
12.

Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia.

Floresco SB, Geyer MA, Gold LH, Grace AA.

Schizophr Bull. 2005 Oct;31(4):888-94. Epub 2005 Aug 3.

PMID:
16079387
13.

Pharmacological strategies for enhancing cognition in schizophrenia.

Barch DM.

Curr Top Behav Neurosci. 2010;4:43-96. Review.

PMID:
21312397
14.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
15.

Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.

Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR.

Am J Psychiatry. 2008 Feb;165(2):221-8. doi: 10.1176/appi.ajp.2007.07010089. Epub 2008 Jan 2.

PMID:
18172017
16.
17.

Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, Part I.

Chouinard S, Sepehry AA, Stip E.

Clin Neuropharmacol. 2007 May-Jun;30(3):169-82. Review.

PMID:
17545751
18.

The neurobiology of cognition in schizophrenia.

Tamminga CA.

J Clin Psychiatry. 2006;67 Suppl 9:9-13; discussion 36-42. Review.

19.

[Approaches to the development of the Japanese academic version of the MATRICS Consensus Cognitive Battery].

Sato T, Sora I.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Nov;31(5-6):241-4. Japanese.

PMID:
22256613
20.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365

Supplemental Content

Support Center